Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.

Clinical trial NCT06896552 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06896552
Sponsor: Rabin Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Immunotherapy Ketogenic Diet

Start date: 2025-04-01
Primary completion: 2027-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.